Molecular Chaperone-like Properties of an Unfolded Protein, alpha s-Casein*

Jaya BhattacharyyaDagger and Kali P. Das§

From the Protein Chemistry Laboratory, Department of Chemistry, Bose Institute, Calcutta-700 009, India

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

All molecular chaperones known to date are well organized, folded protein molecules whose three-dimensional structure are believed to play a key role in the mechanism of substrate recognition and subsequent assistance to folding. A common feature of all protein and nonprotein molecular chaperones is the propensity to form aggregates very similar to the micellar aggregates. In this paper we show that alpha s-casein, abundant in mammalian milk, which has no well defined secondary and tertiary structure but exits in nature as a micellar aggregate, can prevent a variety of unrelated proteins/enzymes against thermal-, chemical-, or light-induced aggregation. It also prevents aggregation of its natural substrates, the whey proteins. alpha s-Casein interacts with partially unfolded proteins through its solvent-exposed hydrophobic surfaces. The absence of disulfide bridge or free thiol groups in its sequence plays important role in preventing thermal aggregation of whey proteins caused by thiol-disulfide interchange reactions. Our results indicate that alpha s-casein not only prevents the formation of huge insoluble aggregates but it can also inhibit accumulation of soluble aggregates of appreciable size. Unlike other molecular chaperones, this protein can solubilize hydrophobically aggregated proteins. This protein seems to have some characteristics of cold shock protein, and its chaperone-like activity increases with decrease of temperature.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

From the time of synthesis through their entire lifetime in the cell, proteins are under constant threat to structural destabilization because of misfolding, stress, or other unfavorable interactions. Molecular chaperones recognize these unstable nonnative conformers of proteins and bind to them instantly, preventing their aggregation in the cell (1-8). Molecular chaperones comprise several structurally unrelated protein families and assist not only in folding of other proteins but also in subcellular transport, oligomeric assembly, and degradation of undesirable proteins (1-2, 4, 7-8). It is not understood at present whether the chaperone function of a protein is because of the presence of a particular sequence or three-dimensional structure, although the role of higher levels of organization of GroEL, TriC, alpha -crystallin, etc. have been emphasized for their chaperone function (9-12). Although no common sequence has been identified among chaperones of different family of proteins, some common features emerges. Chaperones have distinct hydrophilic and hydrophobic domains to enhance solubility and to bind lipophilic molecules (13-15). Many of them have a characteristic micelle-like-associated structure. GroEL exits as an associated 14-mer (7, 9). TriC has a ring-like structure of 8 to 9 subunits (10). Tubulin, reported recently by us (16) to act like a chaperone, associates to form microtubules. alpha -Crystallin, which belongs to small heat shock protein (sHSP) family (17), has been proposed to have a micellar architecture (11, 12). Even nonprotein biological molecules such as ribosomal RNA (18, 19) and phospholipid (20), which can form micelle-type aggregates, were shown to function as molecular chaperones.

It is long known that casein in bovine skim milk remains as large (40-300 nm) stable micelles (21). Bovine milk contains about 78% casein, of which 65% is alpha -casein. More than 75% of alpha -casein is Ca+2-sensitive and called alpha s-casein (22). The rest is Ca+2-insensitive and is mainly kappa -casein. alpha s-Casein has a molecular mass of 23.6 kDa (23). It is present in the milk of all mammals as a random coil protein (24, 25) and is the major protein constituent of casein micelle (21). In the absence of Ca+2 ions, it is a highly soluble protein. Despite its unorganized secondary and tertiary structure, there are similarities between alpha s-casein and other known chaperones in their tendency to self-associate into micelle-like aggregate. This prompted us to test if alpha s-casein possessed any chaperone-like behavior. In this paper we report for the first time that a random coil protein alpha s-casein can prevent in vitro the thermal aggregation of whey proteins from milk as well as the aggregation of a variety of unrelated proteins/enzymes caused by thermal-, chemical-, and light-induced stress. We also show that unlike other chaperones, alpha s-casein can solubilize hydrophobically aggregated proteins and possesses some features similar to the cold shock proteins (CSP).1

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Materials-- alpha s-Casein, bovine serum albumin (BSA), rhodanese, insulin, carbonic anhydrase, alcohol dehydrogenase from equine lever, and citrate synthase were purchased from Sigma. Whey protein isolate (WPI) was obtained from Le Sueur Isolates (Le Sueur, MN). Dithiothreitol (DTT) was purchased from Sisco Research Laboratory, India. Reagents used for SDS-polyacrylamide gel electrophoresis were from Fisher. All reagents used for making buffer solutions were of analytical grade.

Preparation of beta - and gamma -Crystallin-- Freshly excised bovine eyes were obtained from a local slaughterhouse. The lenses were surgically removed and homogenized in 10 mM Tris-HCl buffer, pH 8.0, containing 0.1 M NaCl and 0.02% (w/v) NaN3. The homogenate was centrifuged at 15,000 × g for 20 min at 4 °C. The supernatant was then loaded to a Sephacryl S-300 column (1.5 cm × 90 cm). Five distinct peaks corresponding to high molecular weight alpha  (alpha H-), low molecular weight alpha  (alpha L-), high molecular weight beta  (beta H-), low molecular weight beta  (beta L-), and gamma -crystallin were obtained. Pooled fractions were stored at -20 °C until use. Only beta L- and gamma -crystallin were used in the present study.

Assay of Aggregation of Protein-- Thermally induced aggregation of proteins was measured in a Shimadzu UV-2401PC spectrophotometer fitted with thermostatic cell holder assembly with electronic temperature control. Protein solution and buffer with or without alpha s-casein were mixed in the cuvette at room temperature and then placed in the thermostatic cell holder, and the apparent absorbance at 400 nm was monitored as a function of time. Aggregation of insulin was assayed as described by us earlier (26). Briefly, insulin was dissolved in a minimum volume of 0.02 M NaOH and immediately diluted in 10 mM phosphate buffer, pH 7.0. The aggregation of insulin B-chain was initiated by adding to insulin solution (0.35 mg/ml) DTT (from a 500 mM stock solution) to a final concentration of 20 mM. The extent of aggregation was followed by measuring apparent absorbance because of light scattering at 400 nm. The ultraviolet light-induced aggregation of gamma -crystallin (27, 28) was followed in a Hitachi F-4500 spectrofluorometer by setting both excitation and emission wavelengths at 295 nm with excitation and emission slits of 10 and 5 mm, respectively.

Gel Filtration-- The gel filtration of the samples was performed using a prepacked column (1 × 30 cm) of Suparose 12 attached to a fast protein liquid chromatography system of Amersham Pharmacia Biotech. Protein samples with or without alpha s-casein were first heated at the given temperature and immediately put on ice to bring the temperature to 25 °C. The solution was filtered through a 0.22-µm filter before 100 µl of it was loaded onto the column equilibrated with 20 mM sodium phosphate buffer of pH 7.0. Elution was carried out at a flow rate of 1.0 ml/min. Samples were monitored by their absorbance at 280 nm.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Prevention of thermal aggregation of substrate proteins by molecular chaperones is a commonly used method for in vitro assay of their activity. When solutions of substrate proteins such as alcohol dehydrogenase, carbonic anhydrase, and beta -crystallin are heated at 40, 60, and 60 °C, respectively, the solutions get turbid because of the formation of large aggregates. Fig. 1 shows the kinetic traces of the apparent absorbance at 400 nm of these proteins in the presence and absence of alpha s-casein. In the absence of alpha s-casein, the substrates at the respective temperatures undergo denaturation followed by aggregation. However in the presence of alpha s-casein, aggregation was suppressed. Approximately 92% protection was found at a 1:1 (w/w) ratio of alcohol dehydrogenase:alpha s-casein (Fig. 1A). Complete protection occurred at a 1:1.5 (w/w) ratio of alcohol dehydrogenase:alpha s-casein, corresponding to a mole ratio of 1:4. In the case of beta -crystallin (Fig. 1B), complete suppression of aggregation required a beta -crystallin:casein weight ratio 1:0.3 (1:0.6 molar ratio). At 1:3.5 weight ratio between carbonic anhydrase and alpha s-casein, 90% protection was obtained (Fig. 1C), and complete protection required approximately a 1:5 molar ratio (data not shown). alpha s-Casein was also effective in preventing thermal aggregation of a number of other proteins, including citrate synthase, gamma -crystallin, and rhodanese (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Prevention of thermal aggregation of proteins by alpha s-casein. A, aggregation assay of alcohol dehydrogenase (0.4 mg/ml, 10 mM phosphate buffer, pH 7.0, 40 °C). Curve a, only alcohol dehydrogenase; curve b, plus 0.1 mg/ml alpha s-casein. B, aggregation assay of beta L-crystallin (0.2 mg/ml, 10 mM phosphate, pH 7.0, 60 °C). Curve a, only beta L-crystallin; curve b, plus 0.03 mg/ml alpha s-casein; and curve c, plus 0.06 mg/ml alpha s-casein. C, aggregation assay of carbonic anhydrase (0.1 mg/ml, 10 mM phosphate buffer, pH 7.0, 60 °C). Curve a, only carbonic anhydrase; curve b, plus 0.35 mg/ml alpha s-casein.

Milk contains a number of globular proteins such as beta -lactoglobulin, alpha -lactalbumin, BSA, etc., collectively called whey proteins, which are highly sensitive to temperature, pH, and other conditions (22, 23, 29). WPI is a mixture of these proteins (about 20% of total milk proteins), which remain in the milk serum after removal of casein (29). When 0.5 mg/ml WPI solution in phosphate buffer, pH 6.6, is heated to 70 °C, the solution develops visible turbidity with time because of aggregation (Fig. 2A, trace 1). The presence of 0.4 mg/ml alpha s-casein completely prevents this aggregation (Fig. 2A, trace 2). Similarly, when 0.5 mg/ml BSA solution at pH 6.6 was heated at 70 °C, a low level of scattering was visible because of aggregated proteins (Fig. 2B, trace 1). The presence of 0.5 mg/ml completely prevents the formation of scattering BSA particles (Fig. 2B, trace 2). Our results show that alpha s-casein not only prevents the aggregation of unrelated proteins but also protects its natural substrates in vivo against thermal aggregation. Early work by Morr and co-workers (30, 31) also clearly demonstrated that whole casein prevented gross heat-induced aggregation of whey proteins through nonspecific interaction, even in calcium-containing systems.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Prevention of thermal aggregation of whey proteins by alpha s-casein. A, aggregation assay of whey protein isolate (0.5 mg/ml, 10 mM phosphate buffer, pH 6.6, 70 °C). Curve 1, only whey protein isolate; curve 2, plus 0.4 mg/ml alpha s-casein. B, aggregation assay of bovine serum albumin (0.5 mg/ml, 10 mM phosphate buffer, pH 6.6, temperature 70 °C). Curve 1, only bovine serum albumin; curve 2, plus 0.5 mg/ml alpha s-casein.

Many investigators (32-38) have extensively studied the thermal aggregation properties of whey proteins. It is well known that the major whey proteins beta -lactoglobulin, alpha -lactalbumin, and BSA have disulfide bridges, and the former two have free thiol groups as well (21-23, 29). It was shown that thermal aggregation of whey protein was caused by a combination of hydrophobic as well as thiol-disulfide interchange reactions (34-38). alpha s-Casein, being a highly hydrophobic protein, interacts instantly with the exposed hydrophobic groups of denaturing proteins, preventing aggregation. However we feel that the lack of disulfide bridges and free thiol groups in alpha s-casein sequence (39) is another very important and unique feature that plays a significant role in inhibiting thiol-disulfide interchange reactions. These covalent reactions require close contact of appropriate residues, and alpha s-casein creates a nonreactive barrier by placing itself between the whey proteins.

Whey proteins under various conditions are also known to form soluble aggregates, which apparently cannot be detected by the light-scattering technique we have employed as the aggregation assay method. To check if alpha s-casein can prevent formation of soluble aggregates of appreciable size, we have employed a gel filtration assay using fast protein liquid chromatography. Although alpha -lactalbumin does not aggregate on its own on heating, it is known to form soluble aggregates in the presence of beta -lactoglobulin in the early stages of heat treatment (36, 37). A mixture of alpha -lactalbumin (2 mg/ml) and beta -lactoglobulin (2 mg/ml) at pH 7.0 was heated to 70 °C for 5 min and rapidly cooled to room temperature. The sample on gel filtration showed the presence of aggregated species of molecular mass in excess of 300 kDa eluting at the void volume, unreacted proteins corresponding to dimeric beta -lactoglobulin (36.5 kDa), monomeric alpha -lactalbumin (14.4 kDa), and some intermediate aggregates centered around molecular masses of approximately 100-120 kDa (Fig. 3, trace 1). In the presence of alpha s-casein (4 mg/ml), a considerable reduction in the high molecular mass species was observed, and most of the proteins was eluted in a relatively single peak centered around 60 kDa. In presence of 6 mg/ml casein, no trace of any species of more than ~80 kDa was observed. This clearly shows that in presence of sufficient quantity of alpha s-casein formation of soluble aggregates of any appreciable size is prevented.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of alpha s-casein on the aggregate size of heated mixtures of alpha -lactalbumin (2 mg/ml) and beta -lactoglobulin (2 mg/ml) in 10 mM phosphate buffer, pH 7.0. Trace 1, only alpha -lactalbumin and beta -lactoglobulin heated at 70 °C for 5 min; trace 2, plus alpha s-casein, (4 mg/ml); trace 3, plus alpha s-casein (6 mg/ml). Arrows on top show elution peaks of the standards.

For nonthermal aggregation of substrate proteins, insulin became a popular choice for as the assay system, because reduction of disulfide bond by DTT leads to aggregation of its B-chain at room temperature (16, 26, 40). Like other chaperones, alpha s-casein also can prevent disulfide cleavage-induced aggregation of insulin at 27 °C, requiring a 1:0.35 weight ratio between insulin and alpha s-casein for complete prevention of aggregation (Fig. 4, inset). Using this assay system, we investigated the effect of temperature on its chaperoning efficiency. Fig. 4 shows the bar diagram of the percentage protection of insulin aggregation with alpha s-casein (1:0.035 w/w ratio) at 37, 27, 22, and 18 °C. At 37, 27, and 22 °C, the suppression of aggregation is 39, 52, and 90%, respectively, whereas there was complete protection against insulin aggregation at 18 °C at the same ratio. This finding was in sharp contrast to the behavior of other known chaperones such as alpha -crystallin, tubulin, etc., whose activity were generally found to increase with the increase of temperature (16, 26, 27). Also unlike other chaperones (16, 26, 27), preheating of alpha s-casein solution to 50 °C for 30 min and cooling back to 27 °C did not alter its chaperone efficiency.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   Percentage protection of DTT-induced aggregation of insulin B-chain with alpha s-casein. Insulin concentration was 0.25 mg/ml and alpha s-casein concentration was 0.01 mg/ml at each temperature. The inset shows the aggregation of insulin and its complete protection by 0.1 mg/ml alpha s-casein at 27C.

alpha s-Casein can also prevent other nonthermal aggregation of proteins as well such as those induced by UV light. The eye lens protein gamma -crystallin in solution on being exposed to UV light (295 nm) becomes turbid because of aggregation (27, 28). Like the chaperone-like alpha -crystallin, alpha s-casein also can prevent this aggregation (Fig. 5). Complete prevention requires a 1:2 weight ratio between alpha -crystallin and alpha s-casein, corresponding to a molar ratio of ~1:0.7.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Photo-aggregation of 0.2 mg/ml gamma -crystallin in absence (curve A) and presence (curve B) of 0.4 mg/ml alpha s-casein. 295 nm wavelength light from a spectrofluorometer was used to irradiate the sample, and emission due light scattering at the same 295-nm wavelength was measured to monitor aggregation.

It is known that molecular chaperones bind only aggregation-prone conformers of the substrate protein but do not interact with native proteins or proteins that have already aggregated (41). To test if alpha s-casein acted similarly, we started an insulin aggregation reaction by adding DTT to it, and when nearly 50% aggregation occurred, we added alpha s-casein to the reaction mixture. Our results show that alpha s-casein not only prevented further aggregation of insulin, but unlike other known chaperones, it also slowly solubilized the already-aggregated insulin (Fig. 6). It has also been observed that GroEL can prevent aggregation of substrate proteins both on the unfolding and refolding pathway (42, 43) (e.g. on dilution from 6 M guanidine hydrochloride solution). However, unlike GroEL but like alpha -crystallin (42), alpha s-casein can effectively prevent aggregation in the unfolding pathway but fails to prevent aggregation completely on the refolding pathway (data not shown).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of addition of casein on partially aggregated insulin in 10 mM phosphate buffer, pH 7.0. The kinetics of DTT-induced aggregation of 0.35 mg/ml insulin was followed at 400 nm. 0.7 mg/ml alpha s-casein was added at 2900 s, and kinetics were continued for 12,000 s.

We have thus identified alpha s-casein, which exits in nature as an unfolded random coil protein, as having chaperone-like functions. Like all other known chaperones, it can prevent irreversible aggregation of proteins induced by thermal as well as nonthermal stress by providing hydrophobic surfaces to unfolding proteins. The important features responsible for its chaperone-like activity are (i) its high hydrophobicity characterized by Bigelow's parameter of 1170 (44) along with high estimated net negative charge of about 22 at pH 6.5 (39), (ii) its highly flexible nature because of the relatively high amount (8.5%) of proline residues distributed uniformly throughout the chain (29, 39), (iii) its lack of a cystine residue in the sequence (39). Interestingly alpha s-casein possesses a few features similar to that of the CSP. Generally CSPs in bacteria have higher levels of expression following a cold shock (45) and play a major regulatory role in the activation (46) and physiology of adaptation to low temperature (45). Similarly greater amounts of alpha s-casein are found in mammals of the low temperature zones such as reindeer (47), moose, yak, etc. compared with mammals living in other temperature zones (21). CSPs are known to be devoid of disulfide bonds in their sequence (48) and so is alpha s-casein (39). These similarities between alpha s-casein and CSPs of prokaryotes might suggest that alpha s-casein act as a CSP in eukaryotes.

It is now recognized that molecular chaperones, all of which are known to date, are folded protein molecules and provide guidance to newly synthesized peptides through the folding process, and their presence is essential for cell survival (1-3, 5-8). How the chaperones themselves get folded, however, remains a mystery. It is too early to say if alpha s-casein in vivo may help fold other proteins. It has very recently been shown that cyclophilin was able to refold properly from the unfolded state in the presence of alpha -casein (43). The discovery of RNA chaperones is considered to be of vital importance because their early appearance in the evolution is believed to have made the transition from RNA to a protein/RNA world by rescuing the RNA from possible kinetic trap (49). It has recently been hypothesized that proteins in the early stages of evolution of life were unfolded proteins, which through long evolutionary process ultimately became folded (50). Our observation for the first time that a commonly occurring unfolded protein alpha s-casein can function as a molecular chaperone may be significant in understanding this aspect.

    FOOTNOTES

* This work was supported by the Council of Scientific and Industrial Research CSIR grant No. 37 (0943)/97/EMR-II (to K. P. D.) and Department of Biotechnology (DBT), Government of India.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Research associate under the Umbrella Program of the Department of Biotechnology.

§ To whom correspondence should be addressed: Dept. of Chemistry, Bose Institute, Main campus, 93/1 A.P.C. Rd. Calcutta-700 009, India. Tel.: 91 33 350 6619; Fax: 91 33 350 6790; E-mail: kalipada{at}boseinst.ernet.in.

    ABBREVIATIONS

The abbreviations used are: CSP, cold shock proteins; BSA, bovine serum albumin; DTT, dithiothreitol; WPI, whey protein isolate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
  1. Sigler, P. B., Xu, Z., Rye, H. S., Burston, S. G., Fenton, W. A., and Horwich, A. L. (1998) Annu. Rev. Biochem. 67, 581-608[CrossRef][Medline] [Order article via Infotrieve]
  2. Netzer, W. J., and Hartl, F. U. (1998) Trends Biochem. Sci. 23, 68-73[CrossRef][Medline] [Order article via Infotrieve]
  3. Gething, M. J. (ed) (1997) Guidebook to Molecular Chaperones and Protein-Folding Catalysts, Sambrook and Tooze at Oxford University Press, Oxford
  4. Das, K. P., Petrash, J. M., and Surewicz, W. K. (1996) J. Biol. Chem. 271, 10449-10452[Abstract/Free Full Text]
  5. Frydman, J., and Hohfeld, J. (1997) Trends Biochem. Sci. 22, 87-92[CrossRef][Medline] [Order article via Infotrieve]
  6. Ruddon, R. W., and Bedows, E. (1997) J. Biol. Chem. 272, 3125-3128[Free Full Text]
  7. Hartl, F. U. (1996) Nature 381, 571-580[CrossRef][Medline] [Order article via Infotrieve]
  8. Ellis, R. J. (1996) Science 272, 1448-1449[Medline] [Order article via Infotrieve]
  9. Braig, K., Otwinowski, Z., Hedge, R., Biosvert, D. C., Joachimak, A., Horwich, A. L., and Sigler, P. B. (1994) Nature 371, 578-585[CrossRef][Medline] [Order article via Infotrieve]
  10. Rommelaere, H., Van Troys, M., Gao, Y., Melki, R., Cowan, N. J., van der Kerckhove, J., and Ampe, C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11975-11979[Abstract]
  11. Smulders, R. H. P. H., van Boekel, M. A. M., and de Jong, W. W. (1998) Int. J. Biol. Macromol. 22, 187-196[CrossRef][Medline] [Order article via Infotrieve]
  12. Walsh, M. T., Sen, A. C., and Chakrabarti, B. (1991) J. Biol. Chem. 266, 20079-20084[Abstract/Free Full Text]
  13. Sharma, K. K., Kaur, H., Kumar, S. G., and Kester, K. (1998) J. Biol. Chem. 273, 8965-8970[Abstract/Free Full Text]
  14. Sharma, K. K., Kumar, S. G., Murphy, A. S., and Kester, K. (1998) J. Biol. Chem. 273, 15474-15478[Abstract/Free Full Text]
  15. Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A. L., and Hartl, F. U. (1991) Nature 352, 36-42[CrossRef][Medline] [Order article via Infotrieve]
  16. Guha, S., Manna, T. K., Das, K. P., and Bhattacharyya, B. (1998) J. Biol. Chem. 273, 30077-30080[Abstract/Free Full Text]
  17. Merck, K. B., Groenen, P. J. T. A., Voorter, C. E. M., de Haard-Hoekman, W. A., Horwitz, J., Bloemendal, H., and de Jong, W. W. (1993) J. Biol. Chem. 268, 1046-1052[Abstract/Free Full Text]
  18. Das, B., Chattopadhyay, Bera, A. K., and Dasgupta, C. (1996) Eur. J. Biochem. 235, 613-621[Abstract]
  19. Kudlicki, W., Coffman, A., Kramer, G., and Hardesty, B. (1997) Folding Design 2, 101-108[Medline] [Order article via Infotrieve]
  20. Bogdanov, M., Sun, J., Kaback, H. R., and Dowhan, W. (1996) J. Biol. Chem. 271, 11615-11618[Abstract/Free Full Text]
  21. Waugh, D. F. (1971) in Milk Proteins: Chemistry and Molecular Biology (McKenzie, H. A., ed), Vol. 2, pp. 3-79, Academic Press, New York
  22. Jenness, R. (1970) in Milk Proteins: Chemistry and Molecular Biology (McKenzie, H. A., ed), Vol. 1, pp. 17-40, Academic Press, New York
  23. Kinsella, J. E. (1984) CRC Crit. Rev. Food Sci. Nutr. 21, 197-262
  24. Susi, H., Timasheff, S. N., and Stevens, L. (1967) J. Biol. Chem. 242, 5460-5466[Abstract/Free Full Text]
  25. Creamer, L. K., Richardson, T., and Parry, D. A. D. (1981) Arch. Biochem. Biophys. 211, 689-696[Medline] [Order article via Infotrieve]
  26. Das, K. P., and Surewicz, W. K. (1995) FEBS Lett. 369, 321-325[CrossRef][Medline] [Order article via Infotrieve]
  27. Bhattacharyya, J., and Das, K. P. (1998) Biochem. Mol. Biol. Intl. 46, 249-258[Medline] [Order article via Infotrieve]
  28. Raman, B., and Rao, Ch. M. (1994) J. Biol. Chem. 269, 27264-27268[Abstract/Free Full Text]
  29. Morr, C. V., and Ha, E. Y. W. (1993) Crit. Rev. Food Sci. Nutr. 33, 431-476[Medline] [Order article via Infotrieve]
  30. Morr, C. V., and Josephson, R. V. (1968) J. Dairy Sci. 51, 1349-1355
  31. Kenkare, D. B., Morr, C. V., and Gould, I. A. (1964) J. Dairy Sci. 47, 947-952
  32. Ruegg, M., Moor, U., and Blanc, B. (1977) J Dairy Res. 44, 509-515
  33. De Wit, J. N., Klarenbeck, G., and Hontelez-Backx, E. (1983) Neth. Milk Dairy J. 37, 37-43
  34. Xiang, Y. L. (1992) J. Agric. Food Chem. 40, 380-384
  35. Gezimati, J., Singh, H., and Creamer, L. K. (1996) ACS Symp. Ser. 650, 113-123
  36. Dalgleish, D. G., van Mourik, L., and Corredig, M. (1997) J. Agric. Food Chem. 45, 4806-4813[CrossRef]
  37. Dalgleish, D. G., Senaratne, V., and Francois, S. (1997) J. Agric. Food Chem. 45, 3459-3464[CrossRef]
  38. Laligant, A., Dumay, E, Valencia, C. C., Cuq, J. L., and Cheftel, J. C. (1991) J. Agric. Food Chem. 39, 2147-2155
  39. Mercier, J. C., Grosclaude, F., and Dumas, B. R. (1971) Eur. J. Biochem. 23, 41-51[Medline] [Order article via Infotrieve]
  40. Farahbakhsh, Z. T., Huang, Q. L., Ding, L. L., Altenbach, C., Steinhoff, H. J., Horwitz, J., and Hubbell, W. L. (1995) Biochemistry 34, 509-516[Medline] [Order article via Infotrieve]
  41. Wang, K., and Spector, A. (1994) J. Biol. Chem. 269, 13601-13608[Abstract/Free Full Text]
  42. Das, K. P., and Surewicz, W. K. (1995) Biochem. J. 311, 367-370[Medline] [Order article via Infotrieve]
  43. Wang, J. D., Michelitsch, M. D., and Weissman, J. S. (1998) Proc. Natl. Acad Sci. U. S. A. 95, 12163-12168[Abstract/Free Full Text]
  44. Bigelow, C. C. (1967) J. Theor. Biol. 16, 187-211[Medline] [Order article via Infotrieve]
  45. Graumann, P., and Marahiel, M. A. (1996) Arch. Microbiol. 166, 293-300[CrossRef][Medline] [Order article via Infotrieve]
  46. Jones, P. G., and Inouye, M. (1994) Mol. Microbiol. 11, 811-818[Medline] [Order article via Infotrieve]
  47. McMeekin, T. L., and Polis, B. D. (1949) Adv. Protein Chem. 5, 201-228
  48. Reid, K. L., Rodriguez, H. M., Hiller, B. J., and Gregoret, L. M. (1998) Protein Sci. 7, 470-479[Abstract/Free Full Text]
  49. Herschlag, D. (1995) J. Biol. Chem. 270, 20871-20874[Free Full Text]
  50. Doi, N., and Yanagawa, H. (1998) FEBS Lett. 430, 150-153[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.